Question · Q4 2025
Matt Summerville asked for more detail on X-ray inspection within ATS, specifically why its performance might be decoupled from semi-driven growth and if this is temporary. He also questioned the M&A actionability given the current net leverage and whether the company remains a buyer of its own stock in the open market.
Answer
CEO Sundaram Nagarajan clarified that X-ray inspection's performance is influenced by its automotive exposure and ongoing technology transitions in testing, noting new products are launching and the business is well-positioned for growth. CFO Daniel Hopgood reiterated the consistent M&A strategy of adding differentiated, growth-additive businesses while maintaining financial discipline. He confirmed a balanced capital allocation approach, including continued share repurchases, as the stock still offers upside.
Ask follow-up questions
Fintool can predict
NDSN's earnings beat/miss a week before the call